Denmark’s Novo Nordisk expects 27% sales surge this year but faces price pressure for weight loss drug Wegovy amid Eli Lilly competition Read more
High interest rates and commercial real estate debt have regional banks in a pressure cooker—and an expiring loan program could turn up the heat Read more